However, one interesting fluid biomarker for glial reactivity, glial fibrillary acidic protein (GFAP, a marker of reactive astrocytosis), is measurable from blood using the single molecule array (Simoa) technology and has been recently shown to be associated with Aβ deposition and increased already in early stages of AD [32–34]. Here, GFAP is linked to Alzheimer disease.